A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone.
about
Implication of vaccination against dengue for Zika outbreakPatterns of cellular immunity associated with experimental infection with rDEN2Δ30 (Tonga/74) supports its suitability as a human DENV challenge strainPotent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine.Dengue infection.Zika Virus Vaccine Development.Advancing dengue vaccine development.Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone.
P2860
Q27928012-33E3D6B1-A507-44BF-95C0-42C2ECC0BC76Q28729784-67F47118-0333-40F1-9678-7B5C1801797EQ40040450-2C7D7DA9-A453-4786-AF70-25676A66B1EBQ42996339-8CACA421-54C7-428A-B833-A08505D5C524Q47006432-11702750-54C2-4299-9C23-4B931F2A7CA2Q49952058-A6A3063F-2F7A-4AFC-A0EA-213A76DD48E6Q50223468-5754B4DA-09AB-400C-858B-DB251412D13A
P2860
A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
A recombinant, chimeric tetrav ...... gue virus serotype 2 backbone.
@en
type
label
A recombinant, chimeric tetrav ...... gue virus serotype 2 backbone.
@en
prefLabel
A recombinant, chimeric tetrav ...... gue virus serotype 2 backbone.
@en
P2860
P1476
A recombinant, chimeric tetrav ...... gue virus serotype 2 backbone.
@en
P2093
Dan T Stinchcomb
Derek Wallace
P2860
P304
P356
10.1586/14760584.2016.1128328
P577
2015-12-04T00:00:00Z